My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > DINACICLIB

DINACICLIB

SCH 727965, SCH727965

Catalog No. Product Name Size List Price (US$) Quantity
APIM050142 DINACICLIB 10 mg 100.00
APIM050142 DINACICLIB 50mg 260.00
APIM050142 DINACICLIB 100 mg 380.00
APIM050142 DINACICLIB 200 mg 650.00
Description

Background Information:

Dinaciclib (SCH 727965) is a potent and selective CDK inhibitor and a novel cytotoxic agent. It inhibits CDK2, CDK5, CDK1, and CDK9 activity in vitro with IC50 values of 1, 1, 3, and 4 nM, respectively. It exhibits superior activity, compared with flavopiridol, with a much improved therapeutic index. It is currently in clinical trials.

Reference:

1. D. Parry, et al, Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor, Mol Cancer Ther, 2010, 9(8); 2344–53.
2.  K. Paruch, et al, Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases, ACS Med. Chem. Lett., 2010, 1 (5), pp 204–208.
3. G. Feldmann, et al, Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models, Cancer Biol. Ther. 2011, 12(7), 598-609.

APIM050142: DINACICLIB

CAS No.: 779353-01-4.
Molecular Formula: C21H28N6O2 ? 1/2 H2O.
Molecular Weight: 405.5.
Purity: >99.5% Chem and Optical Purity by achiral and chiral HPLCs.
QC: HPLC-MS, 1HNMR, Chiral HPLC, and Quantitative Elemental Analysis report.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.

Related Links

See our Privacy Policy